Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.…
Izotropic Closes Non-Brokered Private Placement
Izotropic (CNSX: IZO) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector.
The shares were at 0.1250 CAD on 20 November 2026, down 70.9% over 52 weeks. Its 52-week range is 0.1000 CAD to 0.4900 CAD: the price is 74.5% below the high and 25.0% above the low.
Its market capitalisation is 9.04M CAD.
Izotropic reports return on equity of 38.8% and an operating margin of 0.0%.
Its debt exceeds its cash by 3.15M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.
No upcoming events tracked.